Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.

In English

Författare

  • Stefanie Riesenberg
  • Angela Groetchen
  • Robert Siddaway
  • Tobias Bald
  • Julia Reinhardt
  • Denise Smorra
  • Judith Kohlmeyer
  • Marcel Renn
  • Bengt Phung
  • Pia Aymans
  • Tobias Schmidt
  • Veit Hornung
  • Irwin Davidson
  • Colin R Goding
  • Göran B Jönsson
  • Jennifer Landsberg
  • Thomas Tüting
  • Michael Hölzel
Visa allt

Summary, in English

Inflammation promotes phenotypic plasticity in melanoma, a source of non-genetic heterogeneity, but the molecular framework is poorly understood. Here we use functional genomic approaches and identify a reciprocal antagonism between the melanocyte lineage transcription factor MITF and c-Jun, which interconnects inflammation-induced dedifferentiation with pro-inflammatory cytokine responsiveness of melanoma cells favouring myeloid cell recruitment. We show that pro-inflammatory cytokines such as TNF-α instigate gradual suppression of MITF expression through c-Jun. MITF itself binds to the c-Jun regulatory genomic region and its reduction increases c-Jun expression that in turn amplifies TNF-stimulated cytokine expression with further MITF suppression. This feed-forward mechanism turns poor peak-like transcriptional responses to TNF-α into progressive and persistent cytokine and chemokine induction. Consistently, inflammatory MITF(low)/c-Jun(high) syngeneic mouse melanomas recruit myeloid immune cells into the tumour microenvironment as recapitulated by their human counterparts. Our study suggests myeloid cell-directed therapies may be useful for MITF(low)/c-Jun(high) melanomas to counteract their growth-promoting and immunosuppressive functions.

Avdelning/ar

Publiceringsår

2015

Språk

Engelska

Publikation/Tidskrift/Serie

Nature Communications

Volym

6

Dokumenttyp

Artikel i tidskrift

Förlag

Nature Publishing Group

Ämne

  • Cell and Molecular Biology

Status

Published

Forskningsgrupp

  • Melanoma Genomics

ISBN/ISSN/Övrigt

  • ISSN: 2041-1723